| Ardea Biosciences Announces Additional Positive Results from a Phase 2a Study ... - Reuters |
|
|
ReutersA majority of patients randomized to RDEA594 also had mild to moderate renal impairment (Creatinine Clearance by Cockcroft-Gault method = 50-89 ml/min) at ... read more |